
DaVita Inc.
DVANYSEHealthcare● Active
$192.31
+$0.15(+0.08%)
Market Cap$12.3B
P/E Ratio—
52W High$202.69
52W Low$101
DaVita Inc.(DVA)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · DVA · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Cost of Revenue | $9.96B | $8.60B | $8.32B | $8.21B | $7.97B |
| Gross Profit | $3.68B | $4.22B | $3.82B | $3.40B | $3.65B |
| Gross Margin %(computed) | 27.00% | 32.91% | 31.47% | 29.29% | 31.38% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B |
| Total Operating Expenses | $1.67B | $2.13B | $2.22B | $2.06B | $1.85B |
| Operating Income | $2.01B | $2.09B | $1.60B | $1.34B | $1.80B |
| Operating Margin %(computed) | 14.74% | 16.31% | 13.20% | 11.53% | 15.47% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.55B | $0.47B | $0.40B | $0.36B | $0.29B |
| Income Before Tax | $1.35B | $1.53B | $1.18B | $0.97B | $1.52B |
| Income Tax Expense | $0.29B | $0.28B | $0.22B | $0.20B | $0.31B |
| Net Income | $0.75B | $0.94B | $0.69B | $0.56B | $0.98B |
| Net Margin %(computed) | 5.47% | 7.31% | 5.70% | 4.83% | 8.42% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $9.72 | $11.02 | $7.62 | $5.88 | $9.30 |
| Wtd Avg Shares | 0.09B | 0.08B | 0.09B | 0.09B | 0.11B |
| EBITDA | $2.64B | $2.72B | $2.32B | $2.06B | $2.48B |
| EBITDA Margin %(computed) | 19.37% | 21.26% | 19.12% | 17.71% | 21.38% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解DaVita Inc.
关于DaVita Inc.(DVA)损益表
DaVita Inc.(DVA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,DVA实现营收$13.64B,毛利润$3.68B(毛利率27.00%),净利润$0.75B(净利率5.47%)。
常见问题
DVA · 4 问DaVita Inc.(DVA)2025财年营收为$13.64B,同比up6.5%。
DVA revenueDVA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08